Iontophoresis With Potassium Iodide and Thyroid Function

Thyroid Dysfunction Clinical Trial

Official title:

Iontophoresis With Potassium Iodide and the Level of Thyroid Hormones in Healthy Subjects

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04013308
• Other study ID #: URzeszow scientific circle
• Status: Completed
• Phase: N/A
• Start date: May 27, 2019
• Est. completion date: July 31, 2019

Study information

• Verified date: August 2019
• Source: University of Rzeszow
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of the study: To assess the influence of iontophoresis treatment with 2% potassium iodide on the level of thyroid hormones (TSH, FT3, FT4) The study group: conducting 10 iontophoresis treatments with Potassium iodide; The control group: conducting 10 placebo treatments with iontophoresis with destilled water; Intervention: 10 iontophoresis treatments with 2% potassium iodide in healthy individuals.

Test the level of thyroid hormones before and after the 10 iontophoresis treatments; The study allows to assess the influence of iodine on the function of thuroid gland.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 56
• Est. completion date: July 31, 2019
• Est. primary completion date: July 30, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 19 Years to 23 Years

Eligibility

Inclusion Criteria:

• healthy individuals with normal thyroid function

Exclusion Criteria:

• individuals with thyroid disorders,

• taking thyroid medication,

• using drugs, alcohol, cigaretttes

Related Conditions & MeSH terms

• Thyroid Diseases
• Thyroid Dysfunction

Intervention

Procedure:
• Iontophoresis with 2% potassium iodide
10 iontophoresis treatments with 2% potassium iodide on the area of thyroid gland; electrodes with tin foil (Amperage:2mA, duration: 30min)

Locations

Country	Name	City	State
Poland	Centre for Innovative Research in Medical and Natural Sciences' Medical Faculty of University of Rzeszow	Rzeszów	Podkarpackie

Sponsors (1)

Lead Sponsor	Collaborator
University of Rzeszow

Country where clinical trial is conducted

Poland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	the level of thyroid gland hormones (TSH, FT3, FT4)	to test thyroid hormones before and after 10 iontophoresis treatments	change in the thyroid hormones level from the baseline to 14 days after the last treatment